Min KK (2024) Systemic treatment after locoregional recurrence in breast cancer: a review. J Breast Disease 12:1–11. https://doi.org/10.14449/jbd.2024.12.1.1

Article  Google Scholar 

Datta NR, Jain BM, Mathi Z et al (2022) Hyperthermia: a potential game-changer in the management of cancers in low-middle-income group countries. Cancers (Basel). https://doi.org/10.3390/cancers14020315

Article  PubMed  PubMed Central  Google Scholar 

Maluta S, Kolff MW (2015) Role of hyperthermia in breast cancer locoregional recurrence: a review. Breast Care (Basel) 10:408–412. https://doi.org/10.1159/000440792

Article  PubMed  PubMed Central  Google Scholar 

Modi S, Jacot W, Iwata H et al (2025) Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized phase 3 DESTINY-Breast04 trial. Nat Med. https://doi.org/10.1038/s41591-025-03981-4

Article  PubMed  PubMed Central  Google Scholar 

Arciero C, Thompson P, Meisel JL, Taylor CE, Torres MA, Wood WC (2018) Multidisciplinary approaches to chest wall recurrences of breast cancer. Oncol (Williston Park) 32:392–396

Google Scholar 

Datta NR, Puric E, Klingbiel D, Gomez S, Bodis S (2016) Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 94:1073–1087. https://doi.org/10.1016/j.ijrobp.2015.12.361

Article  PubMed  Google Scholar 

Datta NR, Ordonez SG, Gaipl US et al (2015) Local hyperthermia combined with radiotherapy and/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev 41:742–753. https://doi.org/10.1016/j.ctrv.2015.05.009

Article  CAS  PubMed  Google Scholar 

Linthorst M, Baaijens M, Wiggenraad R et al (2015) Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: results in 248 patients. Radiother Oncol 117:217–222. https://doi.org/10.1016/j.radonc.2015.04.019

Article  PubMed  Google Scholar 

Bakker A, van der Zee J, van Tienhoven G, Kok HP, Rasch CRN, Crezee H (2019) Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: a systematic review. Int J Hyperthermia 36:1024–1039. https://doi.org/10.1080/02656736.2019.1665718

Article  PubMed  Google Scholar 

Geyer CE, Forster J, Lindquist D et al (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355:2733–2743. https://doi.org/10.1056/NEJMoa064320

Article  CAS  PubMed  Google Scholar 

Blum JL, Jones SE, Buzdar AU et al (1999) Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 17:485–493. https://doi.org/10.1200/JCO.1999.17.2.485

Article  CAS  PubMed  Google Scholar 

Waddell T, Kotsori A, Constantinidou A et al (2011) Trastuzumab beyond progression in HER2-positive advanced breast cancer: the Royal Marsden experience. Br J Cancer 104:1675–1679. https://doi.org/10.1038/bjc.2011.138

Article  CAS  PubMed  PubMed Central  Google Scholar 

Royce M, Bachelot T, Villanueva C et al (2018) Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, HER2-negative advanced breast cancer: a clinical trial. JAMA Oncol 4:977–984. https://doi.org/10.1001/jamaoncol.2018.0060

Article  PubMed  PubMed Central  Google Scholar 

Jerusalem G, de Boer RH, Hurvitz S et al (2018) Everolimus plus exemestane vs everolimus or capecitabine monotherapy for estrogen receptor-positive, HER2-negative advanced breast cancer: the BOLERO-6 randomized clinical trial. JAMA Oncol 4:1367–1374. https://doi.org/10.1001/jamaoncol.2018.2262

Article  PubMed  PubMed Central  Google Scholar 

Finn RS, Martin M, Rugo HS et al (2016) Palbociclib and letrozole in advanced breast cancer. N Engl J Med 375:1925–1936. https://doi.org/10.1056/NEJMoa1607303

Article  CAS  PubMed  Google Scholar 

Goetz MP, Toi M, Campone M et al (2017) MONARCH 3: abemaciclib as initial therapy for advanced breast cancer. J Clin Oncol 35:3638–3646. https://doi.org/10.1200/JCO.2017.75.6155

Article  CAS  PubMed  Google Scholar 

Hortobagyi GN, Stemmer SM, Burris HA et al (2016) Ribociclib as first-line therapy for HR-positive advanced breast cancer. N Engl J Med 375:1738–1748. https://doi.org/10.1056/NEJMoa1609709

Article  CAS  PubMed  Google Scholar 

Verma S, Miles D, Gianni L et al (2012) Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med 367:1783–1791. https://doi.org/10.1056/NEJMoa1209124

Article  CAS  PubMed  PubMed Central  Google Scholar 

Modi S, Saura C, Yamashita T et al (2020) Trastuzumab deruxtecan in previously treated HER2-positive breast cancer. N Engl J Med 382:610–621. https://doi.org/10.1056/NEJMoa1914510

Article  CAS  PubMed  Google Scholar 

Cortes J, Kim SB, Chung WP et al (2022) Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer. N Engl J Med 386:1143–1154. https://doi.org/10.1056/NEJMoa2115022

Article  CAS  PubMed  Google Scholar 

Bardia A, Hurvitz SA, Tolaney SM et al (2021) Sacituzumab govitecan in metastatic triple-negative breast cancer. N Engl J Med 384:1529–1541. https://doi.org/10.1056/NEJMoa2028485

Article  CAS  PubMed  Google Scholar 

Perez CA, Pajak T, Emami B, Hornback NB, Tupchong L, Rubin P (1991) Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors: final report by the radiation therapy oncology group. Am J Clin Oncol 14:133–141

Article  CAS  PubMed  Google Scholar 

Vernon CC, Hand JW, Field SB et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 35:731–744

Article  CAS  PubMed  Google Scholar 

Skinner HD, Strom EA, Motwani SB et al (2013) Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy. Radiat Oncol 8:13. https://doi.org/10.1186/1748-717X-8-13

Article  PubMed  PubMed Central  Google Scholar 

Wahl AO, Rademaker A, Kiel KD et al (2008) Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. International Journal of Radiation Oncology*Biology*Physics 70:477–484. https://doi.org/10.1016/j.ijrobp.2007.06.035

Article  Google Scholar 

Oldenborg S, Griesdoorn V, van Os R et al (2015) Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: size matters. Radiother Oncol 117:223–228. https://doi.org/10.1016/j.radonc.2015.10.017

Article  PubMed  Google Scholar 

Oldenborg S, Rasch CRN, van Os R, et al.: Reirradiation + hyperthermia for recurrent breast cancer en cuirasse. Strahlenther Onkol. 2018, 194:206-214. 10.1007/s00066-017-1241-7 https://doi.org/10.1007/s00066-017-1241-7